Close Menu

NEW YORK – Thermo Fisher Scientific announced on Tuesday a pair of collaborations for development of its proteomics tools and workflows.

One agreement, with German informatics firm MSAID, provides Thermo Fisher with an exclusive license to develop and commercialized deep learning tools for proteomics based on MSAID's informatics package, which is based on the Prosit software developed at the Technical University of Munich.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.

Sep
09
Sponsored by
10x Genomics

Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems.